James E. Foley

Insulin Resistance and Insulin Secretory Dysfunction as Precursors of Non-Insulin-Dependent Diabetes Mellitus: Prospective Studies of Pima Indians

Stephen Lillioja, David M. Mott, Maximilian Spraul et al. · New England Journal of Medicine · 1993 · 1.5K citations · Full text

Enlarged subcutaneous abdominal adipocyte size, but not obesity itself, predicts Type II diabetes independent of insulin resistance

C. Weyer, James E. Foley, Clifton Bogardus et al. · Diabetologia · 2000 · 785 citations · Full text

Obesity, Metabolic Syndrome, Insulin Resistance +7

Vildagliptin, a Dipeptidyl Peptidase-IV Inhibitor, Improves Model-Assessed β-Cell Function in Patients with Type 2 Diabetes

Andrea Mari, William M. Sallas, Yanling He et al. · The Journal of Clinical Endocrinology & Metabolism · 2005 · 361 citations · Full text

A high concentration of fasting plasma non-esterified fatty acids is a risk factor for the development of NIDDM

Giuseppe Paolisso, P. Antonio Tataranni, James E. Foley et al. · Diabetologia · 1995 · 352 citations

Metabolic Syndrome, Nutrition, High Concentration +10

Vildagliptin therapy reduces postprandial intestinal triglyceride-rich lipoprotein particles in patients with type 2 diabetes

Niina Matikainen, S. Mänttäri, Anja Schweizer et al. · Diabetologia · 2006 · 334 citations · Full text

Metabolic Syndrome, Cardiovascular Disease, Diabetes +9